Omnicell (OMCL) Change in Accured Expenses (2010 - 2026)
Omnicell's (OMCL) quarterly Change in Accured Expenses came in at $14.4 million in Q2 2026, up 2301.84% year-over-year from $598625.0 in Q2 2025, and up 233.56% quarter-over-quarter from -$10.8 million in Q1 2026.
Analysis
Omnicell (OMCL) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Change in Accured Expenses for 17 consecutive years, with $14.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 2301.84% year-over-year to $14.4 million in Q2 2026; TTM through Jun 2026 was -$461000.0, a 95.48% increase from a year earlier, with the FY2025 full-year figure at -$19.0 million, down 235.97% from the prior year.
- Change in Accured Expenses was $14.4 million for Q2 2026 at Omnicell, up from -$10.8 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $44.6 million in Q4 2022 and troughed at -$25.2 million in Q1 2023.
- A 5-year average of -$345111.1 and a median of -$1.5 million in 2024 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 268.1% in 2022 and soared 2301.84% in 2026, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $44.6 million in 2022, then sank by 82.22% to $7.9 million in 2023, then slipped by 11.98% to $7.0 million in 2024, then plunged by 184.51% to -$5.9 million in 2025, then jumped by 343.78% to $14.4 million in 2026.
- The last three Change in Accured Expenses figures came in at $14.4 million (Q2 2026), -$10.8 million (Q1 2026), and -$5.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 50.56 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 14.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.38 Mn |
| Mar 31, 2026 | -10.77 Mn |
| Dec 31, 2025 | -5.90 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | -653,000.00 |
| Mar 31, 2025 | -14.23 Mn |
| Dec 31, 2024 | 6.98 Mn |
| Sep 30, 2024 | -2.28 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | -10.28 Mn |
| Dec 31, 2023 | 7.93 Mn |
| Sep 30, 2023 | -8.41 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | -25.17 Mn |
| Dec 31, 2022 | 44.59 Mn |
| Sep 30, 2022 | -16.82 Mn |
| Jun 30, 2022 | 12.74 Mn |
| Mar 31, 2022 | -23.86 Mn |
| Dec 31, 2021 | 14.71 Mn |
| Sep 30, 2021 | 10.01 Mn |